Trial record 1 of 1 for:
H-200-001
A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04180215 |
|
Recruitment Status :
Recruiting
First Posted : November 27, 2019
Last Update Posted : May 15, 2024
|
Sponsor:
Hookipa Biotech GmbH
Information provided by (Responsible Party):
Hookipa Biotech GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2025 |
| Estimated Study Completion Date : | June 2026 |